UroGen Pharma (URGN) Closes Q3 2025 With $127.4 Million in Cash Amid Rising R&D Costs

17 11 月, 2025

One Min Read

7 Views

原文: https://finance.yahoo.com/news/urogen-pharma-urgn-closes-q3-031407584.html

Last Update: 17 11 月, 2025

Written By

Other Articles

Previous

Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA’s 75% Growth in U.S. Prostacyclin Revenue

Next

RBC Capital Remains Bullish on Viridian Therapeutics (VRDN) Following Q3 2025 Results

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept